Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Employer
-
Field
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
is a network of four national research centers across the Nordics and the European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
of the European Molecular Biology Laboratory (EMBL) www.embl.de/ . The place of work will be at the Michael Sars Centre. The preferred starting time is May - September 2024. Requirements Research
-
research centers across the Nordics and the European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the
-
program of the Nordic EMBL Partnership for Molecular Medicine. The partnership is a network of four national research centers across the Nordics and the European Molecular Biology Laboratory (EMBL), with
-
Health + Life Science Alliance Heidelberg Mannheim | Mannheim, Baden W rttemberg | Germany | 2 months ago
Mannheim (UMM), the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), the Max-Planck-Institute for Medical Research (MPImR), and the Central Institute for Mental Health
-
Molecular Biology Laboratory (EMBL), the Max-Planck-Institute for Medical Research (MPImR), and the Central Institute for Mental Health (ZI Mannheim) have the common goal to develop the Rhine-Neckar region
-
, Biosciences, and Engineering Sciences, the University Hospital Heidelberg (UKHD) and the University Hospital Mannheim (UMM), the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory